D Robert Siemens
Overview
Explore the profile of D Robert Siemens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
257
Citations
2708
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jenkins D, Hosier G, Whitehead M, Beiko D, McGregor T, Nashed J, et al.
Can Urol Assoc J
. 2024 Oct;
19(1):E36-E43.
PMID: 39470664
Introduction: We aimed to assess the relationship between the distance traveled to receive treatment for urolithiasis and early outcomes. Methods: Using administrative data, patients who received interventions for urolithiasis in...
2.
3.
Halstuch D, Kool R, Marcq G, Breau R, Black P, Shayegan B, et al.
J Urol
. 2024 Jul;
212(5):710-719.
PMID: 39051515
Purpose: Outcomes of radiation-based therapy (RT) for muscle-invasive bladder cancer (MIBC) with histologic subtypes of urothelial cancer (HS-UC) are lacking. Our objective was to compare survival outcomes of pure urothelial...
4.
Pare J, Tabasinezhad M, Grossman A, Atallah A, Hindmarch C, Tyryshkin K, et al.
Bladder Cancer
. 2024 Jul;
9(2):175-186.
PMID: 38993297
Background: The mode of action of Bacillus Calmette-Guérin (BCG) in the treatment of patients with non-muscle invasive bladder cancer (NMIBC) is incompletely understood, but recent studies support an association between...
5.
Leveridge M, Siemens D
Can Urol Assoc J
. 2024 Jul;
18(6):155.
PMID: 38976975
No abstract available.
6.
7.
8.
Atallah A, Grossman A, Nauman R, Pare J, Khan A, Siemens D, et al.
Int J Cancer
. 2024 Mar;
155(2):352-364.
PMID: 38483404
Treatment for higher-risk non-muscle invasive bladder cancer (NMIBC) involves intravesical immunotherapy with Bacillus Calmette Guérin (BCG); however, disease recurrence and progression occur frequently. Systemic immunity is critical for successful cancer...
9.
10.